Insulet (PODD) Tops Q2 EPS by 21c
Tweet
Share
E-mail
Get Alerts PODD Hot Sheet
Price: $148.03 +5.96%
Financial Fact:
Cost of revenue: 39.23M
Today's EPS Names:
SCWO, HSAI, SYRS, More
Financial Fact:
Cost of revenue: 39.23M
Today's EPS Names:
SCWO, HSAI, SYRS, More
Join SI Premium – FREE
(Updated - August 5, 2026 7:19 AM EDT)
Insulet (NASDAQ: PODD) reported Q2 EPS of $1.66, $0.21 better than the analyst estimate of $1.45. Revenue for the quarter came in at $801.7 million versus the consensus estimate of $787.82 million.
Raises adjusted EPS growth guidance from >25% to >30%. Cuts FY revenue outlook growth from 21-23% to 20-22%.
For earnings history and earnings-related data on Insulet (PODD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Toll Brothers (TOL) Tops Q3 EPS by 5c, reaffirms guidance
- Trump highlights ibogaine development push, Psyence BioMed responds
- Mercury Systems (MRCY) Misses Q4 EPS by 2c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
